Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 2024
DOI: 10.1038/s41416-024-02662-2
Links
Tools
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer
Journal article published in 2024 by
Koji Haratani 
,
Atsushi Nakamura,
Nobuaki Mamesaya,
Kenji Sawa,
Yoshimasa Shiraishi,
Ryota Saito,
Junko Tanizaki,
Yosuke Tamura,
Akito Hata,
Kosuke Tsuruno,
Tomohiro Sakamoto,
Shunsuke Teraoka,
Masahide Oki,
Hiroshi Watanabe,
Takaaki Tokito
and other authors.
,
Atsushi Nakamura,
Nobuaki Mamesaya,
Kenji Sawa,
Yoshimasa Shiraishi,
Ryota Saito,
Junko Tanizaki,
Yosuke Tamura,
Akito Hata,
Kosuke Tsuruno,
Tomohiro Sakamoto,
Shunsuke Teraoka,
Masahide Oki,
Hiroshi Watanabe,
Takaaki Tokito
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 